PATENT CLAIM ANALYSIS

Application Number: 15781756
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "394000"]

Abstract:
The present invention is directed to a method for preventing and/or treating aging-related cognitive impairment in the central nervous system. The method comprises administering to a subject in need thereof a Ppargc1a activator 2-(4-tert-butylphenyl)-1H-benzimidazole, 2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazole, in an effective amount. A preferred route of administration is oral administration.

Claim (Index 3):
The method according to  claim 1 , wherein said method suppresses neuroinflammation and/or systemic inflammation of the subject.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15518438', '11473196', '13579555', '15241821', '14145303']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6893305286625709
- 35 USC 102 Novelty (BERT): 0.5132856592795024
- Combined Prediction Score: 0.6717260417242641
- Mean Citation Score: 152.612124
- Max Citation Score: 237.13669
- Similarity Product: 157.9211222355527

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test